|
NEC Fingerprint Identification Contributes to the Provision of Legal Identity for Newborn Children in Developing Countries
TOKYO, Jun, 20 2019 - (JCN Newswire) - NEC Corporation (TSE: 6701) has announced the successful conclusion of fingerprint identification technology trials with newborn children from as young as 2 to 24 hours old in the Republic of Kenya. This trial is expected to help establish a reliable foundation for biometric authentication of newborn children in emerging countries.
 | | Collection of newborn fingerprints ensures proper registration and identification |
The ability to collect and authenticate biometric information at an early age enables authorities to provide legal identity, including birth registration, for newborn children, ensures proper identification as they are discharged from the hospital, and supports the accurate management of vaccination schedules. This demonstration capitalized on continuous field research that began in 2016, resulting in an error rate of just 0.3%(1), and was carried out in coordination with the NUITM-KEMRI Project (Nagasaki University Institute of Tropical Medicine-Kenya Medical Research Institute Project).
Currently, there are approximately 1 billion people worldwide without legal identity(2). In addition, an estimated 5.6 million children under the age of 5, including 2.6 million newborns, lose their lives each year. Most of these deaths are considered to be from illness that can be avoided through preventative measures and treatments(3).
In order to solve this problem, it is necessary to establish methods for registering and identifying newborn children as well as recording their medical history. This is especially important in regions where newborn children are often released from healthcare facilities in as few as 6 hours after birth. In addition to the importance of being able to verify the identity of children when they leave healthcare facilities, it is also vitally important to be able to confirm the vaccination schedules of children within 14 weeks of birth(4).
Moreover, as children grow and mature, this identification system can assist with ensuring that children are placed in schools at the most appropriate timing, leading to the advancement of educational opportunities.
NEC?s fingerprinting technology is designed to cause minimal stress for newborn children after caregivers have provided informed consent to taking their children's biometric data.
This initiative helps to promote the 17 Sustainable Development Goals (SDGs) established by the United Nations, particularly Goal 16, Target 16.9: By 2030, provide legal identity for all, including birth registration(5).
Going forward, NEC aims to provide this technology for practical use within biometric authentication infrastructure and national identity systems in emerging countries throughout the world. In addition, it hopes to centralize the authentication of patients who visit public hospitals and to enable convenient access to their medical history. This will help to minimize the loss of medical information and to prevent errors in treatment due to lack of patient information. This information may also contribute to the understanding of civil registration and vital statistics (CRVS) in the near future.
NEC has positioned the safety business centered on Bio-IDiom(6) as a global-growth engine in its 2020 Mid-term Management Plan, a three-year medium-term management plan up to FY2020. NEC has also strengthened business under the NEC Safer Cities(7) initiative. In the future, NEC will continue to focus on the Safety Business to expand its social solutions business.
Overview of technology enhancements in testing trials
Improved Imaging Accuracy
In order to collect the fingerprints of newborn children within a few hours of being born, NEC adopted a high-resolution image sensor with a high-resolution imaging element of 10 micrometers, and combined special glass for enhancing patterns. This made it possible to capture high-definition images of "valley line" patterns of approximately 20 micrometers.
Enhancement of imaging functions and design
In order to eliminate blurring due to the movement of newborn children's fingers during the fingerprint capturing process, the frame rate was increased from the previous 2 frames per second (fps) to a 7 fps rate, and the sensor area was equipped with a blurring prevention function. In addition, NEC adopted specialized equipment that is optimally designed for newborn children, featuring contours that ensure that children?s soft fingers are not pressed strongly against imaging surfaces and guides that ensure the most appropriate direction and position of a subject's finger.
(1) According to NEC research
(2) World Bank Group;
new windowhttp://www.worldbank.org/en/programs/id4d
(3) UNICEF; "Levels & Trends in Child Mortality Report 2017" P1, October 2017
(4) UNICEF; https://www.unicef.org/immunization/index_75054.html
(5) United Nations, "General assembly 15-15900 (E) "p.26, September 2015.
(6) Bio-IDiom
"Bio-IDiom" is NEC's portfolio of biometric identification solutions, including face, iris, fingerprint, palm print, finger vein, voice, and ear acoustic solutions.
https://www.nec.com/en/global/solutions/biometrics/index.html
(7) NEC Safer Cities:
NEC's business domain supporting the realization of safe, secure, efficient, and fair cities by utilizing advanced AI and IoT-related technologies, including biometric certification and video analysis. https://www.nec.com/en/global/solutions/safercities/index.html
About NEC Corporation
NEC Corporation is a leader in the integration of IT and network technologies that benefit businesses and people around the world. The NEC Group globally provides "Solutions for Society" that promote the safety, security efficiency and fairness of society. Under the company's corporate message of "Orchestrating a brighter world," NEC aims to help solve a wide range of challenging issues and to create new social value for the changing world of tomorrow. For more information, visit NEC at https://www.nec.com.
Source: NEC Corporation
Sectors: Electronics, Security/Biometrics
Copyright ©2019 JCN Newswire. All rights reserved. A division of Japan Corporate News Network. |
Latest Release
Eisai and Meiji Announce Parkinson's Disease Treatment Equfina Tablets (Safinamide Mesilate) Approved In Japan
Sep 20, 2019 16:13 JST
| 
MHIENG Completes Large-Scale Polyethylene Production Train for ExxonMobil in Beaumont, Texas
Sep 20, 2019 16:05 JST
| 
Toyota to Hold 30th Toyota Automobile Museum Classic Car Festival in Japan
Sep 20, 2019 16:02 JST
|
Cumulative Global Sales of the Toyota Land Cruiser Series Surpass 10 Million Units
Sep 20, 2019 15:55 JST
| 
The Honda Prize 2019 Awarded to Dr. Geoffrey Hinton, Professor Emeritus, the University of Toronto and Chief Scientific Adviser, Vector Institute
Sep 20, 2019 15:48 JST
| 
Fujitsu and PeptiDream Leverage Quantum-Inspired Tech in Joint Research to Accelerate Drug Discovery
Sep 20, 2019 12:03 JST
| 
Hitachi: Chaskey Message Authentication Technology Developed for IoT Systems Supporting Key Infrastructure Adopted by ISO/IEC for Lightweight Cryptography
Sep 20, 2019 11:05 JST
|
Eisai's Promotion and Distribution Agreement with Mylan India for Eribulin Second Brand in India
Sep 20, 2019 09:40 JST
|
Honda's Cumulative Worldwide Power Products Production Reaches 150 million Units
Sep 19, 2019 20:20 JST
|
Eisai to Present Latest Data on Lemborexant at World Sleep Congress
Sep 19, 2019 20:06 JST
|
Toyota to Invest R$1 Billion in its Plant in Brazil to Produce New Vehicle
Sep 19, 2019 14:11 JST
|
Fujitsu Launches IoT Measuring device for more efficient measurements in the Apparel Industry
Sep 19, 2019 11:41 JST
|
Eisai Selected for Membership in Dow Jones Sustainability Asia Pacific Index 2019
Sep 18, 2019 21:40 JST
| 
Mitsubishi Motors Hosts World Debuts of Small Electric SUV Concept Car at 46th Tokyo Motor Show 2019
Sep 18, 2019 21:31 JST
| 
KDDI Joins Merpay, LINE Pay, and NTT DOCOMO's Merchant Alliance "Mobile Payment Alliance (MoPA)"
Sep 18, 2019 21:19 JST
|
DOCOMO to Commence Deployment of World's First 4G/5G Multi-vendor Radio Access Network Conforming to O-RAN Specifications
Sep 18, 2019 15:12 JST
|
FDA Approves LENVIMA (lenvatinib) Plus KEYTRUDA (pembrolizumab) Combination Treatment for Patients with Certain Types of Endometrial Carcinoma
Sep 18, 2019 14:58 JST
|
MHI-MME to Take Over Production of MET Turbochargers
Sep 18, 2019 14:46 JST
| 
KAHRAMAA, QEWC and MHPS Sign MOU on Internship Program for Young Qatari Engineers
Sep 18, 2019 14:41 JST
|
Toyota Installs Stationary Fuel Cell Generator Based on the Mirai FC System at its Honsha Plant in Japan
Sep 18, 2019 13:34 JST
|
More Latest Release >>
|